Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice-Reference-Cited by-同舟云学术

Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice

Published:2019-06 Issue: Volume:151 Page:136-143
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Manjavachi Marianne N.,Passos Giselle F.,Trevisan Gabriela,Araújo Suzana B.,Pontes Jaqueline P.,Fernandes Elizabeth S.^ORCID,Costa Robson^ORCID,Calixto Joao B.^ORCID

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq

CNPq-INCT-INOVAMED

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES

Fundação de Amparo à Pesquisa do Estado de Santa Catarina

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference41 articles.

1. Permeability of injured and intact peripheral nerves and dorsal root ganglia;Abram;Anesthesiology,2006

2. Mechanical allodynia and enhanced responses to capsaicin are mediated by PI3K in a paclitaxel model of peripheral neuropathy;Adamek;Neuropharmacology,2019

3. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors;Bachelerie;Pharmacol. Rev.,2014

4. Danirixin: a reversible and selective antagonist of the CXC chemokine receptor 2;Busch-Petersen;J. Pharmacol. Exp. Ther.,2017

5. Chemokine receptor CXCR2 in dorsal root ganglion contributes to the maintenance of inflammatory pain;Cao;Brain Res. Bull.,2016

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain;Inflammopharmacology;2024-05-18

2. Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling;Journal of Experimental & Clinical Cancer Research;2024-04-23

3. Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents;Journal of Chemotherapy;2024-01-05

4. Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain;Molecules;2023-07-30

5. The role of CXCL1/CXCR2 axis in neurological diseases;International Immunopharmacology;2023-07